Computed tomography in nonalcoholic fatty liver disease: A useful tool for hepatosteatosis assessment?

Digestive Diseases and Sciences

Volumn 51, Issue 2, 2006, Pages 346-351

  Duman, Deniz Güney ^a   Celikel, Cigdem ^a   Tüney, Davut ^a   Imeryüz, Nese ^a   Avsar, Erol ^a   Tözün, Nurdan ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Computed tomography; Hepatic iron overload; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Spleen minus liver attenuation difference

Indexed keywords

ADULT; ARTICLE; ATTENUATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; IRON OVERLOAD; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL;

ADULT; AGE FACTORS; BODY MASS INDEX; FATTY LIVER; FEMALE; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPLEEN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644888029     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-3136-9     Document Type: Article

References (21)

1. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, Paolis P, Capussotti L, Salizzoni M, Rizzetto M: Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123:134-140, 2002
2. AGA: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123:1705-1725, 2002
3. Neuschwander-Tetri BA, Caldwell SH: Nonalcoholic steatohepatitis: Summary of an AASLD single topic conference. Hepatology 37:1202-1219, 2003
4. Duman DG, Tüney D, Çelikel Ç, Avşar E, Akpinar İ, Bekiroǧlu N, Tözün N: Value of computed tomography in nonalcoholic steatohepatitis (NASH): comparison with liver biopsy. J Hepatol 34 (Suppl 1):195A, 2001
5. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ: The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123:745-750, 2002
6. Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Sponseller CA, Hampton K, Bacon BR: Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. J Hepatol 38:434-440, 2003
7. KiyiciM, Gülten M, Gürel S, Nak SG, Dolar E, Savci G, Adim SB, Yerci Ö, Memik F: Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. Can J Gastroenterol 17:713-718, 2003
8. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA: Nonalcoholic steatohepatitis: an expanded clinical entity. Gasroenterology 107:1103-1109, 1994
9. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467-2474, 1999
10. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR: Measurement of iron status in patients with chronic hepatitis. Gastroenterology 102:2108-2113, 1992
11. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G: Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 96:2448-2455, 2001
12. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH: Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol 149:543-548, 2003.
13. Mendler MH, Bouillet P, LeSidaner A, Lavoine E, Labrousse F, Sautereau D, Pillegand B: Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 28:785-794, 1998
14. Jacobs JE, Birnbaum BA, Shapiro MA, Langlotz CP, Slosman F, Rubesin SE, Horii SC: Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. AJR 171:659-664, 1998
15. Guyader D, Gandon Y, Deugnier Y, Jouanolle H, Loreal O, Simon M, Bourel M, Carsin M, Brissot P: Evaluation of computed tomography in the assessment of liver iron overload. Gastroenterology 97:737-743, 1989
16. Baron RL, Freeny PC, Moss AA: The liver. In Computed Tomography of the Body with Magnetic Resonance Imaging. Moss AA, Gamsu G, Genant HK (eds). Philadelphia, WB Saunders, 1992, pp 735-821
17. Howard JM, Ghent CN, Carey LS, Flanagan PR, Valberg LS: Diagnostic efficacy of hepatic computed tomography in the detection of body iron overload. Gastroenterology 84:209-215, 1983
18. Macdonald GA, Ward PJ, George DK, Powell LW: Iron and fibrosis in nonalcoholic fatty liver disease. Hepatology 31:549-550, 2000
19. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW: Increased hepatic iron concentration in nonalcoholic Steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311-318, 1998
20. Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, Banner BF: Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 31:421-429, 1999
21. Younossi ZM, Gramlich T, Bacon BR, Matteoni CA, Boparai N, O'neill R, McCullough AJ: Hepatic iron and nonalcoholic fatty liver disease. Hepatology 30:847-850, 1999